Keryx Biopharmaceuticals Inc.’s KERX shares rallied 3.8% on the company’s announcement of additional data from a phase III study on Auryxia for the treatment of iron deficiency anemia (IDA) in patients suffering from …
Stock
Current stock market futures today At www.glasgow.ac.uk/jobs earn ... program wells fargo how quick make …
Software
Investors in Keryx Biopharmaceuticals, Inc. (KERX - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the January 20th, 2017 $9 Call had some of the …
ZACKS1mon
Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) CFO Scott A. Holmes sold 8,447 shares of Keryx Biopharmaceuticals stock in a transaction that occurred on Monday, January 30th. The shares were sold at an …
Middle East
The biopharmaceutical company reported 2Q earnings results today, and withdrew its outlook due to a production issue related to Auryxia Keryx Biopharmaceuticals (NASDAQ:KERX) shares plummeted over 34% during the …
One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
Maxim Group has boosted Keryx Biopharma (NASDAQ:KERX) stock to a Buy in a an analyst note sent to …
Citigroup Inc. upgraded shares of Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) from a sell rating to a neutral rating in a research report released on Wednesday. The brokerage currently has $7.00 price objective on the …
Thecer1mon
Citigroup
Green Square Capital LLC purchased a new position in Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) during the third quarter, Holdings Channel reports. The fund purchased 25,500 shares of the biopharmaceutical …
Green Square railway station
Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) CFO Scott A. Holmes sold 8,447 shares of Keryx Biopharmaceuticals stock in a transaction on Monday, January 30th. The stock was sold at an average price …
Holmes